Mint tablets (Mentha piperitae tablets)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Similar drugsTo uncover
Dosage form: & nbsplozenges
Composition:

For one tablet:

active substance: myat pepper leaf oil (peppermint oil) 2.50 mg;

Excipients: fromacharose 391.50 mg, silicon dioxide colloid 2.0 mg, magnesium stearate 4.0 mg.

Description:

Round, flat tablets, white or almost white, light marble is allowed, with the smell of peppermint oil, with risk on one side and chamfers from both sides.

Pharmacotherapeutic group:Spasmolytic agent of plant origin
ATX: & nbsp
  • Preparations for the treatment of functional disorders of the digestive tract
    • Pharmacodynamics:

    Peppermint oil causes irritation of the nerve endings of the oral mucosa, has a moderate spasmolytic, sedative and choleretic effect.

    Indications:

    Applied as a symptomatic for nausea, vomiting, spastic pain of the organs of the gastrointestinal tract.

    Contraindications:

    Hypersensitivity to the components of the drug, inflammatory diseases of the oral mucosa, a deficiency of sugar / isomaltase, intolerance to fructose, glucose-galactose malabsorption, age to 18 years.

    Carefully:

    Diabetes mellitus, cholelithiasis.

    Pregnancy and lactation:

    Use of the drug is possible after consultation with a doctor.

    Dosing and Administration:

    Apply 1-2 tablets 3-4 times a day. The tablets are kept in the mouth until complete resorption. The maximum daily dose is 8 tablets. The course of treatment without a doctor's consultation is 3 days.

    Side effects:

    Possible: allergic reactions, irritation of the oral mucosa.

    In case of adverse reactions, the drug should be discontinued.

    Overdose:

    To date, cases of overdose have not been reported.

    Interaction:

    Weakens the effect of homeopathic medicines.

    Special instructions:

    For patients with diabetes mellitus: 1 tablet contains 0.03 XE, the maximum daily dose contains 0.24 XE.

    Effect on the ability to drive transp. cf. and fur:
    The use of the drug does not affect the ability to perform potentially dangerous types of activities, requiring increased concentration of attention and speed of psychomotor reactions (vehicle management, work with moving mechanisms).
    Form release / dosage:

    Tablets for resorption, 2.5 mg.

    Packaging:

    For 10 tablets in a contour mesh box made of polyvinylchloride film and aluminum foil printed lacquered.

    By 10, 20, 30, 40, 50, 60, 70, 80, 90 or 100 tablets in cans of polymeric for medicines.

    One jar or 1, 2, 3, 4, 5, 6, 7, 8 or 10 contour squares, together with instructions for use, are placed in a cardboard package.

    Storage conditions:

    Keep in a dark place, at a temperature of no higher than 25 ° C.

    Keep out of the reach of children.

    Shelf life:

    3 years.

    Do not use after the expiration date.

    Terms of leave from pharmacies:Without recipe
    Registration number:LP-001961
    Date of registration:27.12.2012 / 28.12.2017
    Expiration Date:Unlimited
    The owner of the registration certificate:ATOLL, LLC ATOLL, LLC Russia
    Manufacturer: & nbsp
    Representation: & nbspOZONE LLC OZONE LLC Russia
    Information update date: & nbsp21.05.2018
    Illustrated instructions
      Instructions
      Up